Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.4841 USD
−11.86 M USD
3.41 M USD
26.61 M
About NeuroOne Medical Technologies Corporation
Sector
Industry
CEO
David A. Rosa
Website
Headquarters
Eden Prairie
Founded
2009
FIGI
BBG001K7WBS9
NeuroOne Medical Technologies Corp. is a medical technology company, which engages in the development and commercialization of thin film electrode technology for continuous electroencephalogram and stereoelectrocencephalography recording, spinal cord stimulation, brain stimulation, and ablation solutions. The company was founded by Mark Christianson on August 20, 2009 and is headquartered in Eden Prairie, MN.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of NMTC is 0.7908 USD — it has decreased by −0.49% in the past 24 hours. Watch NeuroOne Medical Technologies Corporation stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange NeuroOne Medical Technologies Corporation stocks are traded under the ticker NMTC.
NMTC stock has risen by 24.02% compared to the previous week, the month change is a −3.01% fall, over the last year NeuroOne Medical Technologies Corporation has showed a −46.20% decrease.
NMTC reached its all-time high on Aug 21, 2018 with the price of 30.0000 USD, and its all-time low was 0.5101 USD and was reached on May 13, 2022. View more price dynamics on NMTC chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
NMTC stock is 42.65% volatile and has beta coefficient of 1.19. Track NeuroOne Medical Technologies Corporation stock price on the chart and check out the list of the most volatile stocks — is NeuroOne Medical Technologies Corporation there?
Today NeuroOne Medical Technologies Corporation has the market capitalization of 23.31 M, it has increased by 40.02% over the last week.
Yes, you can track NeuroOne Medical Technologies Corporation financials in yearly and quarterly reports right on TradingView.
NeuroOne Medical Technologies Corporation is going to release the next earnings report on Feb 18, 2025. Keep track of upcoming events with our Earnings Calendar.
NMTC earnings for the last quarter are −0.11 USD per share, whereas the estimation was −0.09 USD resulting in a −22.22% surprise. The estimated earnings for the next quarter are −0.10 USD per share. See more details about NeuroOne Medical Technologies Corporation earnings.
NMTC net income for the last quarter is −2.77 M USD, while the quarter before that showed −2.86 M USD of net income which accounts for 3.07% change. Track more NeuroOne Medical Technologies Corporation financial stats to get the full picture.
No, NMTC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 18, 2024, the company has 16.00 employees. See our rating of the largest employees — is NeuroOne Medical Technologies Corporation on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NeuroOne Medical Technologies Corporation EBITDA is −11.99 M USD, and current EBITDA margin is −344.99%. See more stats in NeuroOne Medical Technologies Corporation financial statements.
Like other stocks, NMTC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NeuroOne Medical Technologies Corporation stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NeuroOne Medical Technologies Corporation technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NeuroOne Medical Technologies Corporation stock shows the sell signal. See more of NeuroOne Medical Technologies Corporation technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.